Skip to content
← Back to this collection

PUBLICATIONS · 37902955

Prognostic impact of lymph node involvement and loss of heterozygosity of 1p or 16q in stage III favorable histology Wilms tumor: A report from Children's Oncology Group Studies AREN03B2 and AREN0532.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Cancer
Publication date
2024 Mar 1
First author
Evageliou N

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Evageliou N
      type
      Author
    2. name
      Renfro LA
      type
      Author
    3. name
      Geller J
      type
      Author
    4. name
      Perlman E
      type
      Author
    5. name
      Kalapurakal J
      type
      Author
    6. name
      Paulino A
      type
      Author
    7. name
      Dix D
      type
      Author
    8. name
      Eklund MJ
      type
      Author
    9. name
      Murphy AJ
      type
      Author
    10. name
      Romao RLP
      type
      Author
    11. name
      Ehrlich PF
      type
      Author
    12. name
      Varela CR
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Evageliou N
      type
      Author
    2. name
      Renfro LA
      type
      Author
    3. name
      Geller J
      type
      Author
    4. name
      Perlman E
      type
      Author
    5. name
      Kalapurakal J
      type
      Author
    6. name
      Paulino A
      type
      Author
    7. name
      Dix D
      type
      Author
    8. name
      Eklund MJ
      type
      Author
    9. name
      Murphy AJ
      type
      Author
    10. name
      Romao RLP
      type
      Author
    11. name
      Ehrlich PF
      type
      Author
    12. name
      Varela CR
      type
      Author
    bibliography ids
    1. nci-bib-3178149486e5859453bd8988
    book metadata
    content sha256
    a87ac688c8ca5d5f76ee8be9815fed122c763340f02b2d1de65a397a71790eb6
    document type
    citation
    dois
    1. 10.1002/cncr.35084
    electronic publication date
    display
    2023 Oct 30
    precision
    day
    year
    2023
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:37902955
    immutable id
    pubmed:37902955@a87ac688c8ca5d5f76ee8be9815fed122c763340f02b2d1de65a397a71790eb6
    journal
    abbreviation
    Cancer
    issn electronic
    1097-0142
    issn print
    0008-543X
    issue
    5
    name
    Cancer
    nlm unique id
    0374236
    pages
    792-802
    volume
    130
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      37902955
      provenance
      batch id
      6d213eecf21b6b7867cb
      provider
      NCBI PubMed ESummary
      record sha256
      77caf0d36cef70cd941c90f4147dc882ddf258ac4f18a0c646c1e2587ad282eb
      response sha256
      684f894a21d8f5f78a3bd0acd8ee4215ff94144487c53dab1056650ee8d6751d
      retrieved at
      2026-09-09T23:48:19.049083+00:00
      publication date
      display
      2024 Mar 1
      precision
      day
      year
      2024
      publication types
      1. Journal Article
      2. Research Support, N.I.H., Extramural
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/37902955/
      title
      Prognostic impact of lymph node involvement and loss of heterozygosity of 1p or 16q in stage III favorable histology Wilms tumor: A report from Children's Oncology Group Studies AREN03B2 and AREN0532.

      Preserved source evidence · Not medical advice